Peritoneal Mesothelioma

Peritoneal mesothelioma is a rare and aggressive cancer primarily caused by asbestos exposure. It develops in the peritoneum�the thin membrane lining the abdominal cavity and surrounding abdominal organs. Although less common than pleural mesothelioma, it is the second most frequently diagnosed type, accounting for approximately 10% to 20% of all mesothelioma cases.

While serious and life-threatening, advances in treatment have improved outcomes for some patients, especially when diagnosed early.

Peritoneal mesothelioma forms in the abdominal lining and often develops decades after asbestos exposure, making early detection difficult.

What Is Peritoneal Mesothelioma?

Peritoneal mesothelioma develops when asbestos fibers are inhaled or ingested and migrate to the abdominal lining. Once embedded in the peritoneum, these fibers cause chronic inflammation, cellular damage, and eventually malignant tumor growth.

Unlike pleural mesothelioma, which affects the lungs, peritoneal mesothelioma impacts the digestive system and abdominal organs. Tumors may spread throughout the abdominal cavity if untreated.

Why Choose Us for Your Asbestos Exposure Claim?

Free No-Obligation Review

We provide free no-obligation A. B. Barone asbestos exposure case review

Contingency Representation

We work on a contingency basis, meaning there are no fees unless we collect for you

Expertise In Asbestos & Mesothelioma Lawsuits

We have experience winning claims against huge multi-national corporations

Symptoms of Peritoneal Mesothelioma

Symptoms typically appear 20 to 50 years after asbestos exposure. Early signs are often vague and resemble common digestive issues, leading to delayed diagnosis.

Common symptoms include:

? Abdominal pain or swelling
? Bloating or fluid buildup (ascites)
? Nausea or vomiting
? Loss of appetite
? Unexplained weight loss
? Fatigue

As the disease progresses, symptoms worsen and may interfere with digestion and daily activities.

Diagnosis of Peritoneal Mesothelioma

Diagnosis involves imaging tests and tissue sampling. Physicians may use CT scans, MRIs, or ultrasounds to detect abnormalities or fluid buildup in the abdomen.

If mesothelioma is suspected, a biopsy is required to confirm the diagnosis. Pathologists examine tissue samples to identify malignant mesothelial cells and determine the cell type. Additional lab tests may help distinguish peritoneal mesothelioma from other abdominal cancers.

Accurate diagnosis is essential for determining treatment options and prognosis.

Prognosis and Treatment Options

Although peritoneal mesothelioma is not curable, treatment advances have improved survival for some patients. Treatment options may include:

? Surgery to remove visible tumors
? Chemotherapy, including heated intraperitoneal chemotherapy (HIPEC)
? Immunotherapy
? Palliative care to manage symptoms

Treatment plans depend on disease stage, tumor spread, overall health, and response to therapy. Some patients respond well to multimodal treatment approaches.

Stages of Peritoneal Mesothelioma

Unlike pleural mesothelioma, peritoneal mesothelioma does not always follow a standardized TNM staging system. Instead, physicians evaluate tumor burden, spread within the abdominal cavity, and lymph node involvement.

Understanding the extent of disease helps specialists recommend appropriate treatment strategies and provide clearer expectations for patients and families.